My Election Journal
SEE OTHER BRANDS

Bringing you the latest news on politics

My Election Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Election Journal.

Press releases published on August 20, 2025

OSE Immunotherapeutics Appoints Thomas Gidoin as  Chief Financial Officer

OSE Immunotherapeutics Appoints Thomas Gidoin as Chief Financial Officer

NANTES, France, August 20, 2025 – 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced the appointment of Thomas Gidoin as Chief Financial Officer. Thomas joins the Executive Committee, bringing over 15 years of deep …

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier

OSE Immunotherapeutics nomme Thomas Gidoin au poste de Directeur Financier

NANTES, France - 20 août 2025, 18 h 00 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), annonce aujourd’hui la nomination de Thomas Gidoin au poste de Directeur Financier. Thomas rejoint le Comité Exécutif, apportant à la Société plus de 15 …

Large Language Model Market Surges to $36.1 billion by 2030 - Dominated by Google (US), OpenAI (US), Anthropic (US)

Large Language Model Market Surges to $36.1 billion by 2030 - Dominated by Google (US), OpenAI (US), Anthropic (US)

Delray Beach, FL, Aug. 20, 2025 (GLOBE NEWSWIRE) -- According to MarketsandMarkets™, the Large Language Model Market is estimated to be worth USD 6.4 billion in 2024 and is projected to reach USD 36.1 billion by 2030 at a CAGR of 33.2% during the forecast …

KULR to Host Booth at Commercial UAV Expo 2025

KULR to Host Booth at Commercial UAV Expo 2025

HOUSTON, Aug. 20, 2025 (GLOBE NEWSWIRE) -- KULR Technology Group, Inc. (NYSE American: KULR) (the "Company" or "KULR"), a Bitcoin-Plus Treasury company that builds a portfolio of frontier technology businesses ranging from high-performance energy systems …

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

Mural Oncology Announces Entry into Agreement to be Acquired by XRA 5 Corp., a wholly owned subsidiary of XOMA Royalty for between $2.035 and $2.24 in Cash per Share

WALTHAM, Mass., DUBLIN, Ireland and EMERYVILLE, Calif., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Mural Oncology plc (Nasdaq: MURA), a clinical-stage immuno-oncology company (“Mural”), and XOMA Royalty Corporation (Nasdaq: XOMA), a biotechnology royalty aggregator …

American Rebel Light Beer Expands into Western North Carolina with Budweiser of Asheville, Inc.

American Rebel Light Beer Expands into Western North Carolina with Budweiser of Asheville, Inc.

Strategic Partnership Strengthens Distribution in 13 States American Rebel Light Beer Continues to Execute Growth Plan with Established Regional Beverage Distribution Leaders like Budweiser of Ashville, Inc. NASHVILLE, TN, Aug. 20, 2025 (GLOBE NEWSWIRE) -- …

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing

Phathom Pharmaceuticals Clarifies That There Is No Reduction in Lead Shareholder’s Ownership Following Administrative Change to 13D Filing

FLORHAM PARK, N.J., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), today clarified that a Schedule 13D filing by Frazier Life Sciences, which is expected to be filed later today, August 20, will include administrative …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions